Waldenström’s Macroglobulinemia Associated with Cryoglobulinemia: Pathogenetic, Clinical, and Therapeutic Aspects

Meletios A Dimopoulos; Efstathios Kastritis

doi:10.1007/978-88-470-1705-4_36

Related publications

Article2000

Waldenström’s Macroglobulinemia: Clinical Features, Complications, and Management

Meletios A Dimopoulos, Panayiotis Panayiotidis, Lia A. Moulopoulos, Petros P. Sfikakis, Marinos C. Dalakas

Article2002

Treatment of Waldenström’s Macroglobulinemia With Rituximab

Meletios A Dimopoulos, Constantinos Zervas, Athanassios Zomas, Christos Kiamouris, Nora Viniou, Vassiliki Grigoraki, Christos Karkantaris, Chrisanthi Mitsouli, Dimitra Gika, John Christakis, Nikolaos Anagnostopoulos

Article2022

Managing Waldenström’s macroglobulinemia with BTK inhibitors

Christian Buske, Wojciech Jurczak, Joe‐Elie Salem, Meletios A Dimopoulos

Letter2001

Treatment of Waldenstrom’s Macroglobulinemia With Thalidomide

Meletios A Dimopoulos, Athanassios Zomas, Nora Viniou, Vassiliki Grigoraki, Eleni Galani, Charis Matsouka, Olga Economou, Nikolaos Anagnostopoulos, Panayiotis Panayiotidis

Article2013

Circulating Levels of Angiogenic Cytokines in Waldenstrom’s Macroglobulinemia: Clinical Correlations

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Meletios A Dimopoulos